REFRACTORY IPA

Clinical trials for REFRACTORY IPA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY IPA trials appear

Sign up with your email to follow new studies for REFRACTORY IPA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

New inhaled therapy for tough fungus infections falls short in trial

Disease control Terminated

This study tested whether adding an inhaled antifungal drug (PC945) to standard treatment could help people with a serious lung fungus infection that wasn't getting better. The trial was stopped early, so we don't have clear proof it works. About 85 adults with proven or probable…

Matched conditions: REFRACTORY IPA

Phase: PHASE3 • Sponsor: Pulmocide Ltd • Aim: Disease control

Last updated May 17, 2026 18:21 UTC

REFRACTORY IPA

Get alerted when new REFRACTORY IPA trials appear

New inhaled therapy for tough fungus infections falls short in trial